Physician profile
Jacob M Mishell
NPI 1487732004
$32,341.02
in general payments reported to CMS, 2019-2025
9 companies · $9,977 in 2025
The $9,977 reported for 2025 was more than what 89% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $264 · 2021: $1,029 · 2022: $1,152 · 2023: $8,634 · 2024: $11K · 2025: $9,977.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $20K · Food and Beverage: $5,972 · Consulting Fee: $4,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $19,923.88 |
| Food and Beverage | $5,971.60 |
| Consulting Fee | $4,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $14,774.05 | 2019-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia, Pascal |
| Medtronic, INC. | $9,854.22 | 2022-2025 | Apollotm, Corevalve Evolut R |
| Boston Scientific Corporation | $4,785.49 | 2023 | |
| Abbott Laboratories | $2,755.69 | 2023-2025 | Triclip, Mitraclip |
| Shockwave Medical, INC | $76.05 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Biosense Webster, INC. | $35.19 | 2023 | Nuvision Ice Catheter |
| Philips North America LLC | $22.79 | 2023 | |
| Angiodynamics, INC. | $19.85 | 2023 | Alphavac |
| Terumo Medical Corporation | $17.69 | 2025 | Tr Band |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacob Mishell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.